As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...